Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsINTRAVENOUSStandard

ADRENALIN

EPINEPHRINE

Standard Dose
8MG/250ML (32MCG/ML)
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary

Approval overview ADRENALIN is listed in Drugs@FDA under application 215875 (NDA).

Review priority: STANDARD Marketing status: Prescription Active ingredient EPINEPHRINE Form and strength SOLUTION;INTRAVENOUS - 8MG/250ML (32MCG/ML) Sponsor PH HEALTH Submission history Latest submission status date: 2023-10-19 00:00:00.

Structured Monograph

Clinical summary

Approval overview ADRENALIN is listed in Drugs@FDA under application 215875 (NDA). Review priority: STANDARD Marketing status: Prescription Active ingredient EPINEPHRINE Form and strength SOLUTION;INTRAVENOUS - 8MG/250ML (32MCG/ML) Sponsor PH HEALTH Submission history Latest submission status date: 2023-10-19 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Prescription
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.